Department profile
Garwin Gerstein & Fisher LLP

Antitrust: Mainly Plaintiff

USA Guide 2026 : New York

Share profile

Garwin Gerstein & Fisher LLP

Chambers Review

Provided by Chambers

Antitrust: Mainly Plaintiff - New York

Band 3

What the Team is Known For

Garwin Gerstein & Fisher LLP represent plaintiffs in a variety of complex antitrust litigation matters. The firm has particular strength in the pharmaceutical space and regularly develops and investigates new cases.

View ranking table

Work Highlights

Provided by Chambers

  • Garwin Gerstein & Fisher LLP serves as co-lead counsel in a case alleging a scheme to delay entry of generic versions of the blockbuster drug Lipitor.

Strengths

Provided by Chambers

  • The firm has leadership of large scale cases involving numerous plaintiffs and defendants and a depth of experience in the pharmaceutical antitrust space.

    Antitrust: Mainly Plaintiff respondentUSA

  • The firm has a deep level of experience and understanding in litigating complex antitrust matters from the filing of the case all the way through a jury verdict and appeals.

    Antitrust: Mainly Plaintiff respondentUSA

  • They are innovative about applying antitrust expertise across new cases and industries.

    Antitrust: Mainly Plaintiff respondentUSA

Garwin Gerstein & Fisher LLP has rankings in the following guides

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership